Clinical Case Report: Treatment of Central Serous Chorioretinopathy – from LIGHTMED

Brought to you by Lightmed

Lightmed’s clinical team shares this educational case report, including success stories from patients.

Click here to read the full report.

Key Points:

• The LIGHTMED TruScan 577nm with SP-Mode® Microsecond Laser Technology is a safe and effective technology to treat central serous retinopathy.

• Early diagnosis and treatment is important in CSC in order to reduce the duration of SRD, and avoid degeneration of the RPE.

• SP-Mode® Microsecond Laser Technology is used in the treatment of warming RPE cells, in order to lead to the “functional remodeling” of the RPE and the subsequent improvement of retinal function.

• The yellow wavelength is well absorbed by the RPE melanin; and thus, it is suitable to treat RPE cells efficiently.

• Test irradiation is important for every patient because each person has a different extent of light absorption. Half of the visible threshold is a safe and effective parameter to treat CSC without scar formations.

• SRF reduction varies among patients, and it is important to wait at least 3 months after treatment to notice SRF reduction.